Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by Veristat

News headline image
Veristat Strengthens Biostatistics, Drug Development Advisory, and People Leadership to Support Growth in Complex Clinical Development
From Veristat
Via Business Wire
News headline image
Veristat Launches AI Biostatistics Platform, Cutting Clinical Trial Data Readout Time from 5 Weeks to 5 Days* Without Regulatory Risks
From Veristat
Via Business Wire
News headline image
Veristat to Acquire Certara’s Regulatory and Medical Writing Business
From Veristat
Via Business Wire
News headline image
Veristat Expands Regulatory and Clinical Services to Chinese Drug and Device Companies Seeking Efficient Way to Enter European Markets
From Veristat
Via Business Wire
News headline image
Veristat Names Industry Veteran Kim McLean Boericke as New Chief Executive Officer
From Veristat
Via Business Wire
News headline image
Veristat and AOBiome Therapeutics to Present at Clinical Outsourcing Group on Essential Elements of Effective Partnerships with CROs
From Veristat
Via Business Wire
News headline image
Cook MyoSite and Veristat Partner in Complex, Phase III, Adaptive Clinical Study of Investigational Cell Therapy for Unmet Need in Women’s Health
From Veristat
Via Business Wire
News headline image
Veristat Congratulates George Medicines on FDA Approval of WIDAPLIK™
From Veristat
Via Business Wire
News headline image
Veristat Appoints Gabriela Rosu, M.D., to Lead Growing Medical Affairs Team
From Veristat
Via Business Wire
News headline image
Veristat Appoints New Chief Commercial Officer
From Veristat
Via Business Wire
News headline image
Veristat Joins the Alliance for Regenerative Medicine (ARM) to Help Address Critical Issues Impacting the Advanced Therapy Sector
From Veristat
Via Business Wire
News headline image
Veristat Acquires Biometrics-focused Instat Clinical Research
From Veristat
Via Business Wire
News headline image
Veristat Acquires European Medical Writing Consultancy Scinopsis
From Veristat
Via Business Wire
News headline image
Veristat Taps Accomplished Industry Leaders to Support Growth and Innovation
From Veristat
Via Business Wire
News headline image
Veristat Congratulates HIPRA for EMA Approval of Its BIMERVAX® COVID-19 Vaccine
From Veristat
Via Business Wire
News headline image
Veristat Supported Eight Regulatory Approvals in 2022, the Majority for Therapies Designed to Treat Rare Diseases
From Veristat
Via Business Wire
News headline image
Veristat Presents Integrated, Customized DCT Solutions at the DTRA Annual Meeting
From Veristat
Via Business Wire
News headline image
Veristat Joins Decentralized Trials & Research Alliance (DTRA) to Improve the Patient Experience
From Veristat
Via Business Wire
News headline image
Veristat is Recognized on the 2022 Inc. 5000 List of America’s Fastest-Growing Private Companies
From Veristat
Via Business Wire
News headline image
Cindy Henderson Named Veristat Chief Commercial Officer
From Veristat
Via Business Wire
News headline image
Veristat Appoints Joe Scott as Chief Financial Officer
From Veristat
Via Business Wire
News headline image
Veristat Supported Marketing Applications for 12% of all FDA Novel Drug Approvals in 2021
From Veristat
Via Business Wire
News headline image
Veristat Strengthens Regulatory Capabilities Across Europe and UK
From Veristat
Via Business Wire
News headline image
Veristat Appoints Colleen Pelton Chief Talent Officer
From Veristat
Via Business Wire
News headline image
Veristat Announces New Investment Partner—WindRose Health Investors
From Veristat
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.